Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

What's Going On With Bitcoin- And Ethereum-Related Stock Coinbase?

Coinbase Global Inc (NASDAQ: COIN) shares are trading higher by 3.48% at $55.59 after the company reported first-quarter results on Wednesday. The stock has been volatile following the report, initially falling late Wednesday.

Benzinga

Nvidia Shares Fall 15% In A Week: What's Going On?

NVIDIA Corp (NASDAQ: NVDA) shares are trading lower Thursday and have fallen more than 15% over the last week.

Benzinga

What's Going On With Amazon Stock?

Amazon.com Inc (NASDAQ: AMZN) shares are trading slightly higher Thursday, but have fallen by about 9% over the last week.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

What's Going On With Apple Stock?

Apple Inc (NASDAQ: AAPL) shares are trading lower Thursday and have fallen by nearly 10% over the last week.

Benzinga

Can LSD Treat Anxiety? MindMed's New Topline Data Show Promise, Here's The Research

MindMed (NASDAQ: MNMD) researchers shared topline clinical results for a Phase 2 LSD clinical study at the recent Psych Symposium, which was co-sponsored by University Hospital Basel (UHB).

Benzinga

Tesla Bulls And Bears Battle It Out: What's Next For The Stock?

Tesla, Inc (NASDAQ: TSLA) bounced up more than 8% off its opening price on Thursday in tandem with the general markets, which saw the S&P 500 spike 1.56% of the open before giving back all of its gains.

Benzinga

What's Going On With Tesla Shares?

Tesla Inc (NASDAQ: TSLA) shares are trading lower Thursday and have fallen nearly 16% over the last week.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

What's Going On With Microsoft Stock?

Microsoft Corp (NASDAQ: MSFT) shares are trading lower Thursday and have fallen nearly 10% over the last week.

Benzinga

Where Bumble Stands With Analysts

Over the past 3 months, 13 analysts have published their opinion on Bumble (NASDAQ:BMBL) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Analyst Ratings for Treace Medical Concepts

Within the last quarter, Treace Medical Concepts (NASDAQ:TMCI) has observed the following analyst ratings:

Benzinga

Rivian Is A 'Show-Me-The-Money' Story But Has 'More Pieces In Place' Than Peers: Analysts React To Q1 Earnings

Electric vehicle company Rivian Automotive Inc (NASDAQ: RIVN) reported first-quarter production of 2,553 vehicles. The company delivered 1,227 vehicles in the first quarter and reported more than 90,000 net pre-orders of its Rivian R1 electric pickup truck.

Benzinga

Insurance Stocks Moving In Thursday's Intraday Session

According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session.

Benzinga

Short Volatility Alert: ServiceSource International

On Wednesday, shares of ServiceSource International, Inc. (NASDAQ: SREV) experienced volatile short activity. After the activity, the stock price went down 1.39% to $1.42. The overall sentiment for SREV has been Bullish.

Benzinga

Short Volatility Alert: Software Acquisition Group

On Wednesday, shares of Software Acquisition Group Inc. III (NASDAQ: SWAG) experienced volatile short activity. After the activity, the stock price moved down 0.10% to $10.00. The overall sentiment for SWAG has been Bearish.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

COCP: Cocrystal Pharma Releases 2022 1st Quarter Results and Provides an Update on the Current Pipeline Programs

By Thomas Kerr, CFA NASDAQ:COCP READ THE FULL COCP RESEARCH REPORT

Benzinga

Expert Ratings for OncoCyte

Within the last quarter, OncoCyte (NASDAQ:OCX) has observed the following analyst ratings:

Benzinga

Looking Into Micron Technology's Recent Short Interest

Micron Technology's (NASDAQ:MU) short percent of float has fallen 14.35% since its last report. The company recently reported that it has 21.25 million shares sold short, which is 1.91% of all regular shares that are available for trading.

Benzinga

Goldman Sachs Maintains Buy Rating for Cytek Biosciences: Here's What You Need To Know

Goldman Sachs has decided to maintain its Buy rating of Cytek Biosciences (NASDAQ:CTKB) and lower its price target from $14.00 to $12.00. Shares of Cytek Biosciences are trading up 10.93% over the last 24 hours, at $8.22 per share.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Cowen & Co. Maintains Market Perform Rating for Beyond Meat: Here's What You Need To Know

Cowen & Co. has decided to maintain its Market Perform rating of Beyond Meat (NASDAQ:BYND) and lower its price target from $42.00 to $26.00. Shares of Beyond Meat are trading up 7.2% over the last 24 hours, at $28.05 per share.

Benzinga

Mid-Day Market Update: Dow Tumbles 350 Points; AppLovin Shares Jump

U.S. stocks traded lower this morning, with the Dow Jones dropping more than 350 points on Thursday.

Benzinga

Stocks That Hit 52-Week Highs On Thursday

On Thursday, 5 companies set new 52-week highs.

Benzinga

58 Stocks Moving In Thursday's Mid-Day Session

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 102.6% to $0.1580 after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering.

Benzinga

Moderna Concludes FDA Submission For Its COVID-19 Shot In Adolescents, Kids

Reuters reported that Moderna Inc (NASDAQ:MRNA) had made required submissions to the FDA for emergency use authorization of its COVID-19 vaccine in adolescents and children. An advisory panel of experts to the U.S. drug regulator will meet in June to review the request. Related: FDA Sets Review Dates For Pfizer, Moderna COVID-19 Shot For…

Benzinga

Micron, Affirm Holdings And 'The Only FANG Worth Buying' Will Be Featured On 'Mad Money' Tonight

Several prominent CEOs are set to be featured on "Mad Money" Thursday night with Jim Cramer. Here's a look at the lineup:

Benzinga

Camtek Clocks 35% Revenue Growth In Q1 Backed By Robust Order Flow Amid China's Covid Lockdown, Global Tensions

Camtek Ltd (NASDAQ:CAMT) reported first-quarter FY22 revenue growth of 35% year-on-year to $77.17 million, marginally beating the consensus of $77 million. The non-GAAP gross margin expanded 130 bps to 52%. The non-GAAP operating margin expanded by 160 bps to 28.8%. Non-GAAP EPS of $0.44 missed the consensus of $0.45. The company held $428.3…

1 … 562 563 564 565

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.